HX Diagnostics (Emeryville, CA) an early-stage diagnostics company developing seasonal and pandemic influenza assays, closed a $3.1M Series A financing. Participants include Kleiner Perkins Caufield & Byers, Nanogen and Xiamen YST Biotech.